Insmed (INSM) Change in Accured Expenses (2010 - 2026)

Insmed's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$33.9 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 44.91% year-over-year to -$33.9 million in Q1 2026; TTM through Mar 2026 was $127.7 million, a 726.62% increase from a year earlier, with the FY2025 full-year figure at $100.1 million, up 124.42% from the prior year.
• Change in Accured Expenses fell to -$33.9 million in Q1 2026 per INSM's latest filing, from $90.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $90.3 million in Q4 2025 and bottomed at -$61.5 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is -$620000.0 (2024), against an average of $5.1 million.
• Across the five-year window, Change in Accured Expenses slumped 2174.61% in 2024 and surged 7448.23% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$27.7 million in 2022, then surged by 84.0% to -$4.4 million in 2023, then surged by 1271.85% to $52.0 million in 2024, then jumped by 73.88% to $90.3 million in 2025, then sank by 137.49% to -$33.9 million in 2026.
• Per Business Quant, the three latest INSM Change in Accured Expenses figures stand at -$33.9 million (Q1 2026), $90.3 million (Q4 2025), and $45.6 million (Q3 2025).